vs
Side-by-side financial comparison of Metallus Inc. (MTUS) and OPKO HEALTH, INC. (OPK). Click either name above to swap in a different company.
Metallus Inc. is the larger business by last-quarter revenue ($308.3M vs $148.5M, roughly 2.1× OPKO HEALTH, INC.). Metallus Inc. runs the higher net margin — 1.8% vs -21.1%, a 22.8% gap on every dollar of revenue. On growth, Metallus Inc. posted the faster year-over-year revenue change (9.9% vs -19.2%). Over the past eight quarters, Metallus Inc.'s revenue compounded faster (2.3% CAGR vs -7.5%).
OPKO Health, Inc. is a medical test and medication company focused on diagnostics and pharmaceuticals. The company is a publicly traded company on NASDAQ and TASE under the symbol "OPK".
MTUS vs OPK — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $308.3M | $148.5M |
| Net Profit | $5.4M | $-31.3M |
| Gross Margin | 8.1% | 43.1% |
| Operating Margin | — | -25.8% |
| Net Margin | 1.8% | -21.1% |
| Revenue YoY | 9.9% | -19.2% |
| Net Profit YoY | 315.4% | -322.8% |
| EPS (diluted) | $0.13 | $-0.04 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $308.3M | — | ||
| Q4 25 | $267.3M | $148.5M | ||
| Q3 25 | $305.9M | $151.7M | ||
| Q2 25 | $304.6M | $156.8M | ||
| Q1 25 | $280.5M | $150.0M | ||
| Q4 24 | $240.5M | $183.6M | ||
| Q3 24 | $227.2M | $173.6M | ||
| Q2 24 | $294.7M | $182.2M |
| Q1 26 | $5.4M | — | ||
| Q4 25 | $-14.3M | $-31.3M | ||
| Q3 25 | $8.1M | $21.6M | ||
| Q2 25 | $3.7M | $-148.4M | ||
| Q1 25 | $1.3M | $-67.6M | ||
| Q4 24 | $-21.4M | $14.0M | ||
| Q3 24 | $-5.9M | $24.9M | ||
| Q2 24 | $4.6M | $-10.3M |
| Q1 26 | 8.1% | — | ||
| Q4 25 | 2.2% | 43.1% | ||
| Q3 25 | 11.4% | 32.9% | ||
| Q2 25 | 10.6% | 31.5% | ||
| Q1 25 | 7.8% | 28.4% | ||
| Q4 24 | 4.5% | 46.1% | ||
| Q3 24 | 5.3% | 23.1% | ||
| Q2 24 | 8.2% | 28.4% |
| Q1 26 | — | — | ||
| Q4 25 | -7.7% | -25.8% | ||
| Q3 25 | 3.6% | 31.7% | ||
| Q2 25 | 2.8% | -38.3% | ||
| Q1 25 | 1.0% | -44.8% | ||
| Q4 24 | -10.1% | -18.0% | ||
| Q3 24 | -3.1% | 8.2% | ||
| Q2 24 | 2.1% | -33.9% |
| Q1 26 | 1.8% | — | ||
| Q4 25 | -5.3% | -21.1% | ||
| Q3 25 | 2.6% | 14.3% | ||
| Q2 25 | 1.2% | -94.7% | ||
| Q1 25 | 0.5% | -45.1% | ||
| Q4 24 | -8.9% | 7.6% | ||
| Q3 24 | -2.6% | 14.3% | ||
| Q2 24 | 1.6% | -5.7% |
| Q1 26 | $0.13 | — | ||
| Q4 25 | $-0.34 | $-0.04 | ||
| Q3 25 | $0.19 | $0.03 | ||
| Q2 25 | $0.09 | $-0.19 | ||
| Q1 25 | $0.03 | $-0.10 | ||
| Q4 24 | $-0.46 | $0.02 | ||
| Q3 24 | $-0.13 | $0.03 | ||
| Q2 24 | $0.10 | $-0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $104.0M | $364.4M |
| Total DebtLower is stronger | — | $344.0M |
| Stockholders' EquityBook value | $683.0M | $1.3B |
| Total Assets | $1.1B | $1.9B |
| Debt / EquityLower = less leverage | — | 0.27× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $104.0M | — | ||
| Q4 25 | $156.7M | $364.4M | ||
| Q3 25 | $191.5M | $412.0M | ||
| Q2 25 | $190.8M | $267.3M | ||
| Q1 25 | $180.3M | $428.8M | ||
| Q4 24 | $240.7M | $426.6M | ||
| Q3 24 | $254.6M | $400.1M | ||
| Q2 24 | $272.8M | $40.6M |
| Q1 26 | — | — | ||
| Q4 25 | — | $344.0M | ||
| Q3 25 | $0 | $344.2M | ||
| Q2 25 | $0 | $343.3M | ||
| Q1 25 | $5.4M | $439.2M | ||
| Q4 24 | $5.4M | $437.2M | ||
| Q3 24 | $13.2M | $441.0M | ||
| Q2 24 | $13.2M | $201.9M |
| Q1 26 | $683.0M | — | ||
| Q4 25 | $686.0M | $1.3B | ||
| Q3 25 | $697.7M | $1.3B | ||
| Q2 25 | $690.0M | $1.3B | ||
| Q1 25 | $686.1M | $1.3B | ||
| Q4 24 | $690.5M | $1.4B | ||
| Q3 24 | $712.7M | $1.4B | ||
| Q2 24 | $736.3M | $1.4B |
| Q1 26 | $1.1B | — | ||
| Q4 25 | $1.1B | $1.9B | ||
| Q3 25 | $1.2B | $2.0B | ||
| Q2 25 | $1.1B | $2.0B | ||
| Q1 25 | $1.1B | $2.1B | ||
| Q4 24 | $1.1B | $2.2B | ||
| Q3 24 | $1.1B | $2.3B | ||
| Q2 24 | $1.1B | $2.0B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.27× | ||
| Q3 25 | 0.00× | 0.26× | ||
| Q2 25 | 0.00× | 0.26× | ||
| Q1 25 | 0.01× | 0.33× | ||
| Q4 24 | 0.01× | 0.32× | ||
| Q3 24 | 0.02× | 0.31× | ||
| Q2 24 | 0.02× | 0.14× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-25.9M |
| Free Cash FlowOCF − Capex | — | $-28.6M |
| FCF MarginFCF / Revenue | — | -19.3% |
| Capex IntensityCapex / Revenue | 0.0% | 1.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-190.8M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-1.9M | $-25.9M | ||
| Q3 25 | $22.0M | $-34.6M | ||
| Q2 25 | $34.8M | $-83.4M | ||
| Q1 25 | $-38.9M | $-34.6M | ||
| Q4 24 | $13.9M | $-44.4M | ||
| Q3 24 | $-15.3M | $-77.1M | ||
| Q2 24 | $8.3M | $-26.4M |
| Q1 26 | — | — | ||
| Q4 25 | $-37.2M | $-28.6M | ||
| Q3 25 | $-6.4M | $-37.8M | ||
| Q2 25 | $17.0M | $-86.7M | ||
| Q1 25 | $-66.4M | $-37.7M | ||
| Q4 24 | $-1.3M | $-49.8M | ||
| Q3 24 | $-32.9M | $-85.0M | ||
| Q2 24 | $-5.8M | $-33.7M |
| Q1 26 | — | — | ||
| Q4 25 | -13.9% | -19.3% | ||
| Q3 25 | -2.1% | -24.9% | ||
| Q2 25 | 5.6% | -55.3% | ||
| Q1 25 | -23.7% | -25.2% | ||
| Q4 24 | -0.5% | -27.1% | ||
| Q3 24 | -14.5% | -49.0% | ||
| Q2 24 | -2.0% | -18.5% |
| Q1 26 | 0.0% | — | ||
| Q4 25 | 13.2% | 1.8% | ||
| Q3 25 | 9.3% | 2.1% | ||
| Q2 25 | 5.8% | 2.1% | ||
| Q1 25 | 9.8% | 2.1% | ||
| Q4 24 | 6.3% | 2.9% | ||
| Q3 24 | 7.7% | 4.6% | ||
| Q2 24 | 4.8% | 4.0% |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 2.72× | -1.60× | ||
| Q2 25 | 9.41× | — | ||
| Q1 25 | -29.92× | — | ||
| Q4 24 | — | -3.17× | ||
| Q3 24 | — | -3.10× | ||
| Q2 24 | 1.80× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MTUS
Segment breakdown not available.
OPK
| Services | $71.1M | 48% |
| Transfer Of Intellectual Property And Other | $33.7M | 23% |
| IE | $22.1M | 15% |
| Rayaldee | $8.8M | 6% |
| Barda Agreement | $6.8M | 5% |
| MX | $6.3M | 4% |
